Apollo Therapeutics
Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating fundamental medical research into medicines using a hub-and-spoke approach. It manages a diversified pipeline of therapeutic programs, leveraging expertise from a centralized team and its partner institutions. The company aims to advance these programs through clinical development and potentially license or acquire additional clinical-stage programs.
Funding Round: Series C
Funding Amount: $260M
Date: 02-Jan-2024
Investors: Patient Square Capital, M&G plc, two of the largest US public pension plans, Rock Springs Capital
Markets: Biopharmaceutical, Pharmaceuticals, Biotechnology, Health Care, Medical, Therapeutics
HQ: Cambridge, Cambridgeshire, United Kingdom
Founded: 2015
Website: http://www.apollotherapeutics.com
LinkedIn: https://uk.linkedin.com/company/apollo-therapeutics
Crunchbase: https://www.crunchbase.com/organization/apollo-therapeutics
Leave a Comment
Comments
No comments yet.